361 related articles for article (PubMed ID: 9885309)
41. Effect of hydrophilic polymers on isradipine complexation with hydroxypropyl β-cyclodextrin.
Mummidi V; Jayanthi V
Drug Dev Ind Pharm; 2013 Jul; 39(7):970-7. PubMed ID: 22612875
[TBL] [Abstract][Full Text] [Related]
42. Inclusion complexation of nimesulide with beta-cyclodextrins.
Vavia PR; Adhage NA
Drug Dev Ind Pharm; 1999 Apr; 25(4):543-5. PubMed ID: 10194611
[TBL] [Abstract][Full Text] [Related]
43. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
44. Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir.
Boudad H; Legrand P; Lebas G; Cheron M; Duchêne D; Ponchel G
Int J Pharm; 2001 May; 218(1-2):113-24. PubMed ID: 11337155
[TBL] [Abstract][Full Text] [Related]
45. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
[TBL] [Abstract][Full Text] [Related]
46. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
Sathigari S; Chadha G; Lee YH; Wright N; Parsons DL; Rangari VK; Fasina O; Babu RJ
AAPS PharmSciTech; 2009; 10(1):81-7. PubMed ID: 19148759
[TBL] [Abstract][Full Text] [Related]
47. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
Patel SG; Rajput SJ
AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
[TBL] [Abstract][Full Text] [Related]
48. Investigation of inclusion complex of epothilone A with cyclodextrins.
Xiao CF; Li K; Huang R; He GJ; Zhang JQ; Zhu L; Yang QY; Jiang KM; Jin Y; Lin J
Carbohydr Polym; 2014 Feb; 102():297-305. PubMed ID: 24507285
[TBL] [Abstract][Full Text] [Related]
49. Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with beta-cyclodextrin and its sulfobutyl ether derivative in solution and solid state.
Ribeiro LS; Ferreira DC; Veiga FJ
Eur J Pharm Sci; 2003 Nov; 20(3):253-66. PubMed ID: 14592691
[TBL] [Abstract][Full Text] [Related]
50. Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl beta-cyclodextrin.
Chowdary KP; Srinivas SV
AAPS PharmSciTech; 2006 Sep; 7(3):79. PubMed ID: 17025259
[TBL] [Abstract][Full Text] [Related]
51. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
Fathy M; Sheha M
Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
[TBL] [Abstract][Full Text] [Related]
52. Characterization and in vivo evaluation of an inclusion complex of oridonin and 2-hydroxypropyl-beta-cyclodextrin.
Yan Z; Xu W; Sun J; Liu X; Zhao Y; Sun Y; Zhang T; He Z
Drug Dev Ind Pharm; 2008 Jun; 34(6):632-41. PubMed ID: 18568914
[TBL] [Abstract][Full Text] [Related]
53. Preparation and characterization of the inclusion complex of furosemide with hydroxypropyl-beta-cyclodextrin.
Vlachou M; Papaïoannou G
J Biomater Appl; 2003 Jan; 17(3):197-206. PubMed ID: 12614084
[TBL] [Abstract][Full Text] [Related]
54. Physico-chemical characterization and in vitro dissolution assessment of clonazepam-cyclodextrins inclusion compounds.
Patel R; Purohit N
AAPS PharmSciTech; 2009; 10(4):1301-12. PubMed ID: 19885735
[TBL] [Abstract][Full Text] [Related]
55. Solid-state characterization and in vitro dissolution behavior of lorazepam: Hydroxypropyl-β-cyclodextrin inclusion complex.
Patel R; Patel M
Drug Discov Ther; 2010 Dec; 4(6):442-52. PubMed ID: 22491310
[TBL] [Abstract][Full Text] [Related]
56. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
57. Influence of amorphous cyclodextrin derivatives on aceclofenac release from directly compressible tablets.
Dahiya S; Pathak K
Pharmazie; 2007 Apr; 62(4):278-83. PubMed ID: 17484283
[TBL] [Abstract][Full Text] [Related]
58. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
[TBL] [Abstract][Full Text] [Related]
59. The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes.
Jambhekar S; Casella R; Maher T
Int J Pharm; 2004 Feb; 270(1-2):149-66. PubMed ID: 14726131
[TBL] [Abstract][Full Text] [Related]
60. Improving the solubility and bioavailability of dihydroartemisinin by solid dispersions and inclusion complexes.
Ansari MT; Batty KT; Iqbal I; Sunderland VB
Arch Pharm Res; 2011 May; 34(5):757-65. PubMed ID: 21656361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
